A New Bevacizumab Carrier for Intravitreal Administration: Focus on Stability

• Autori principali: Daniela Chirio (Autore), Elena Peira (Autore), Simona Sapino (Autore), Giulia Chindamo (Autore), Simonetta Oliaro-Bosso (Autore), Salvatore Adinolfi (Autore), Chiara Dianzani (Autore), Francesca Baratta (Autore), Marina Gallarate (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2021-04-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Bevacizumab (BVZ) is a monoclonal antibody that binds to human vascular endothelial growth factor A (VEGF-A) and inhibits the interaction between VEGF-A and VEGF receptors, thus blocking the angiogenesis. Repeated intravitreal injections of BVZ for the treatment of ocular pathologies that present an...